Schizophrenia Research

Article	Citations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	162
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	101
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	92
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data	83
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	73
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	67
Meta-analysis of a family history of diabetes in schizophrenia	62
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	51
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	48
Frequency of clinical appointments in subjects with emergent suicidal ideation	47
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	47
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	45
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	43
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	43
Issue Highlights	42
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?	42
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	41
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	39
The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study	37
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia	37
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	37
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	36
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	35
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	35
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis	35

A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	34
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital	34
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis	34
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	33
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	32
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	31
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	30
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	30
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study	29
Selection bias in clinical studies of first-episode psychosis: A follow-up study	29
Denial of anosognosia in schizophrenia	28
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	28
The potential of AI for scale development: A self-report psychosis symptoms measure using ChatGPT	28
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature	28
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment	28
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia	27
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	27
Hippocampus in the symptom architecture of schizophrenia spectrum disorders: A network analysis approach	27
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study	27
Association between negative symptoms and health-related quality of life and functional outcomes in persons with schizophrenia: A systematic review	27
Interpersonal distance in schizophrenia: A systematic review	27
Issue Highlights	26
Deciphering language disturbances in schizophrenia: A study using fine-tuned language models	25
Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia	25
Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial	25
Arousal responses to personal space intrusions in psychotic illness: A virtual reality study	25
Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity	25
Clozapine discontinuation and rechallenge in suspected myocarditis: An analysis of seven cases	24
Perceived burdensomeness and thwarted belongingness prospectively influence real-world social support-seeking behavior among emerging adults with first-episode psychosis	24
The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms	24
Insomnia and substance use in psychotic disorders	24
Spontaneous neural activity underlying neutral and happy speech recognition in noise and its association with psychiatric symptoms in patients with schizophrenia	24
Climatic exposures in childhood and the risk of schizophrenia from childhood to early adulthood	24
Acceptance and Commitment Therapy-based Lifestyle Counselling Program for people with early psychosis on physical activity: A pilot randomized controlled trial	24
Computational psychiatry and the psychopathology of psychosis: Promising leads and blind alleys	23
Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia	23
Brief video intervention to reduce stigma of family and friends of people living with serious mental illness	23
Minority stress and schizophrenia-like experiences in sexual and gender minority adults	23
Personal recovery in first-episode psychosis: Beyond clinical and functional recovery	23
Schizophrenia among young people first admitted to psychiatric inpatient care during early and middle adolescence	22
Factors and their weight in reducing life expectancy in schizophrenia	22
Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia	22
A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts	22
Exploring the relationship between the gut microbiota and cognitive function in schizophrenia patients with distinct weights	22
Improving dependability in science: A critique on the psychometric qualities of the HiTOP psychosis superspectrum	22
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study	22
Augmentation of learning in schizophrenia by d-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study	22
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia	22
Advancing the sensori-/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation	21
Relations of temporoparietal connectivity with neighborhood social fragmentation in youth at clinical high-risk for psychosis	21

The infraslow fluctuation of sigma power during sleep in young individuals with schizophrenia	21
The impact of early intervention for first episode psychosis on cognitive functioning	21
Differential gene expression study in whole blood identifies candidate genes for psychosis in African American individuals	21
Abnormalities in motor adaptation to different types of perturbations in schizophreniaperturbations in schizophrenia	20
Mitochondrial dysfunction in psychiatric disorders	20
Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Res	20
Alteration in left frontoparietal connectivity correlates with impaired cognitive reappraisal in early psychosis	20
Racial microaggressions and major discriminatory events explain ethnoracial differences in psychotic experiences	20
I am a person, not an illness	20
Determining the cumulative incidence of treated schizophrenia and predictors of transition in an early intervention for psychosis service	20
A systematic review of dramatherapy interventions used to support adults with psychosis	20
Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models	20
Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls	20
Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview	20
What beneficial effects were maintained following a supervised high intensity interval training intervention among overweight individuals with psychotic disorders?	20
Investigation on the association between perceived family expressed emotion, self-stigma, and subjective quality of life in people with early psychosis in Hong Kong: A cross-sectional approach	19
Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia	19
Overview on cognitive impairment in psychotic disorders: From impaired microcircuits to dysconnectivity	19
Assessing negative symptoms of schizophrenia in the context of remote independent ratings: a psychometric evaluation of BNSS and PANSS	19
Corrigendum to “Jang YJ, et al. Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics” [Schizophr Res. 276 (2025) 88–96 10.1016/j.schres.2025.0	19
Promoting implementation of deployment-ready psychosocial interventions	19
Integrating rare variant genetics and brain transcriptome data implicates novel schizophrenia putative risk genes	19
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial	19
Olfactory dysfunction in schizophrenia and other psychotic disorders: A comprehensive and updated meta-analysis	18
Issue highlights	18
Association between sleep disturbances and gray matter volume in individuals at clinical high-risk for psychosis and healthy controls: A longitudinal MRI study (NAPLS-3)	18
Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies	18
Issue highlights	18
Response to the Letter to the editor: Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study	18
The association between area-level factors and mortality in severe mental illnesses: A systematic review	18
Food and nutrition insecurity among individuals with schizophrenia and related psychotic disorders	18
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial	18
Comparative lipidomic alterations in the anterior cingulate cortex in schizophrenia and major depression	18
Aberrant salience predicts fluctuations of paranoia two weeks in advance during a 1-year experience sampling method study in people with psychosis	18
Insight and suicidality in first-episode psychosis: The mediating role of depression	18
Use and outcomes of antipsychotic medications for delusional and paranoid personality disorders: A population-based study	18
Pathways linking adverse childhood experiences to psychosis risk in Lagos, Nigeria: A structural equation modeling approach	18
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials	17
Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia	17
Neurocognitive function and delusion severity in schizophrenia spectrum disorders	17
Exploring the relationship between baseline health-related quality of life (AQoL-4D utility values) and mortality during long-term follow-up for people living with a psychotic disorder	17
Patient-reported outcome measures in early psychosis: A cross-cultural, longitudinal examination of the self-reported health and self-reported mental health measures in Chennai, India and Montreal, Ca	17
Increased prevalence of the Heschl's gyrus duplication pattern common to various first-episode psychoses	17
Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms	17
Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach	17
Issue Highlights	17
Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self- experience	17
Disrupted static and dynamic small-world brain network topologies in patients with schizophrenia	17
Systematic review and meta-analysis of family-based interventions for early psychosis: Carer and patient outcomes	17
Sulfur-containing amino acids and risk of schizophrenia	17
Predicting future mortality risk in first-episode psychosis: External validation of the MIRACLE-FEP machine learning model	17
Avolition predicts variability in optimal risk-taking in early psychosis	17
Reprint of Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study	16
The phenomenological nature of schizophrenia and disorder of selfhood	16
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells	16
MicroRNA-regulated suppression of some overexpressed genes in schizophrenia and their evolutionary significance	16
COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report	16
Hippocampal volume in affective and non-affective psychosis	16
Associations between fearlessness about death and suicidal ideation in individuals with psychosis	16
Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomes	16
Renaming schizophrenia in Argentina: Could a change of name resolve the stigma? Results from a national survey	16
Learning health systems in early interventions for psychosis: Establishing consumer voices in clinical high-risk for psychosis care	16
Catatonia is associated with higher rates of negative affect amongst patients with schizophrenia and schizoaffective disorder	16
Does affect mediate the relationship between interpersonal trauma and psychosis? A systematic review and meta-analysis	16
Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards	16
Pathways to care: Source of referral at first-episode psychosis, a cross-country comparison between Bologna and South London	16
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated?	16
Effect of schizophrenia risk gene polymorphisms on cognitive and neural plasticity	15
The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences	15
Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis	15
Editorial Board	15
Editorial Board	15
“The second I laid eyes on him I knew”: First impressions predict willingness to interact with individuals with schizophrenia	15
Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats	15
Insulin resistance and lipid levels in the middle-aged offspring of parents with severe mental illness	15
Highlights	15
Reshaping the diagnostic borders: Historical analysis of the diagnostic changes following the introduction of the schizophrenia concept	15
The role of defeatist performance beliefs on cognitive effort-cost decision-making in schizophrenia	15
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia	15
Young first-episode psychosis patients exhibit impaired microvascular function in the skin and low systemic nitric oxide availability, independent of classical cardiovascular risk factors	15

Defeatist beliefs about performance are important treatment targets for negative symptoms in the early course of schizophrenia	15
Subjective self-experiences at the mirror in patients with schizophrenia	15
Evaluating the abnormal neural variability in schizophrenia: A TMS-EEG study	14
Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls	14
Perceptual organization and its visual subcomponents in schizophrenia and schizotypy: A systematic review	14
Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia	14
SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impacts	14
Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure	14
Chicken or the egg: The relationship between cognitive deficits and negative symptoms in first episode psychosis	14
Reevaluating the assessment of nonverbal behavior in psychosis symptomatology: A call for cultural sensitivity	14
Levetiracetam effects on hippocampal blood flow and symptoms in medication-free individuals with nonaffective first episode psychosis (letter)	14
Initial evidence of vowel space reduction in a subset of individuals with schizophrenia	14
Motor activity-based prediction of the presence of apathy in schizophrenia	14
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia	14
Longitudinal analysis of absolute neutrophil count (ANC) variability and neutropenia incidence in African American schizophrenia patients by ACKR1 genotype	14
Catatonia is an outpatient reality. What do we do now?	14
Automatic identification of schizophrenia employing EEG records analyzed with deep learning algorithms	14
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia	14
Disentangling the relationship between psychiatric disorders, cardiometabolic abnormalities, and antipsychotics: A systematic review of genomic studies	14
Schizophrenia, the very idea: On self-disorder, hyperreflexivity, and the diagnostic concept	13
Treatment of schizotypal disorder: A systematic review and GRADE evaluation of the certainty of evidence	13
Why and how might yoga differ from other mind-body approaches in schizophrenia?	13
The cellular mechanism of antipsychotic-induced myocarditis: A systematic review	13
Editorial Board	13
Factor structure of social cognition in schizophrenia: Investigation of four core domains	13
Psychotic-like experiences in a nationally representative study of general population adolescents	13
Functional network interactions in patients with schizophrenia with persistent auditory verbal hallucinations: A multimodal MRI fusion approach using three-way pICA	13
Editorial Board	13
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth	13
The neuromuscular basis of functional impairment in schizophrenia: A scoping review	13
Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capac	13
Everything is connected: Inference and attractors in delusions	13
Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia	13
Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial?	13
Sleep patterns in treated and untreated patients of schizophrenia	13
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone	13
Microstructural white matter biomarkers of symptom severity and therapy outcome in catatonia: Rationale, study design and preliminary clinical data of the whiteCAT study	13
The contributions of risk-taking and impulsivity to jumping to conclusions in the psychosis spectrum	13
Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study	13
Promoting safer and wider worldwide use of clozapine	13
Editorial Board	13
Epidemiology of psychotic-like experiences by subtypes and their relationship with emotional regulation and affective lability among Chinese college students	13
Retinal electrophysiological alterations are associated with cognition in early course psychosis	13
A role for endothelial NMDA receptors in the pathophysiology of schizophrenia	13
Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition	13
Sub-clinical systemic inflammation as a determinant of admission duration in psychosis	12
Reply to dynamic network analysis of schizophrenia spectrum traits, affective symptoms, and social functioning—Opportunities and challenges	12
Is it the end of the clozapine world as we know it? Perspectives on social implications of REMS elimination	12
Reframing schizophrenia: Altering our perceptions?	12
A psychological intervention for engaging dialogically with auditory hallucinations (Talking With Voices): A single-site, randomised controlled feasibility trial	12
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments	12
Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia	12
Dynamic or not, here I come: Ambulatory assessment of psychomotor ability for clinical predictions	12
Utilization of a psychosis consultation service: Early lessons from a statewide initiative	12
Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonan	12
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition	12
Long-term quality of life and social disconnection 20 years after a first episode psychosis, results from the 20-year follow-up of the OPUS trial	12
Predicting the onset of psychotic experiences in daily life with the use of ambulatory sensor data – A proof-of-concept study	12
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia	12
The use of adaptive emotion regulation strategies in people with attenuated psychotic symptoms – Results from a two-week diary study	12
Feasibility and Acceptability of a Physical Activity Group Program Using telerehabilitation during the COVID-19 Pandemic in Multiple early Intervention for Psychosis Services	12
‘Thinking about Them is only making me feel worse’. The mediating role of metacognitive factors in the relationship between paranoia-like beliefs and psychopathology symptoms in a community sample	12
Abnormalities in emotion regulation are associated with negative, but not positive or disorganized schizotypy: An experience sampling study	12
Investigating bilirubin concentrations in schizophrenia: A systematic review and meta-analysis	12
Editorial Board	12
Prenatal infection and schizophrenia: A decade of further progress	12
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data	12
Letter to the editor regarding: Dynamic network analysis of schizophrenia spectrum traits, affective symptoms, and social functioning—Opportunities and challenges	11
Issue Highlights	11
Subtyping chronic catatonia: Clinical and neuropsychological characteristics of progressive periodic catatonia and chronic system catatonias vs. non-catatonic schizophrenia	11
Obsessive-compulsive symptoms and personal recovery in patients with schizophrenia spectrum disorders: A cross-sectional study	11
Clinical phenotypes of five patients with psychotic disorders carrying rare schizophrenia-associated loss-of-function variants	11
High rates of myocarditis with clozapine in the Hunter region of Australia	11
Aberrant salience signaling in auditory processing in schizophrenia: Evidence for abnormalities in both sensory processing and emotional reactivity	11
Sex and pubertal influences on the neurodevelopmental underpinnings of schizophrenia: A case for longitudinal research on adolescents	11
The other side of the social interaction: Theory of mind impairments in people with schizophrenia are linked to other people's difficulties in understanding them	11
HONE: A learning health system platform for advancing early intervention in first episode psychosis	11
Effectiveness of a mindfulness-based intervention for persons with early psychosis: A multi-site randomized controlled trial	11
A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation	11
Issue Highlights	11
Self and time in individuals with schizophrenia: A motor component?	11
Perceptual pathways to hallucinogenesis	11
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies	11
Guest editorial: Social determinants of health in the psychosis spectrum	11
Rich-club connectivity and structural connectome organization in youth at clinical high-risk for psychosis and individuals with early illness schizophrenia	11
Development and validation of a neutrophil-lymphocyte ratio-based nomogram for suicidal ideation in first-episode drug-naïve schizophrenia patients: A large-scale cross-sectional study	11
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study	11
Impact of lifetime stressor exposure on neuroenergetics in schizophrenia spectrum disorders	11
Neuroanatomical subtypes of schizophrenia and relationship with illness duration and deficit status	11
Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disorders	11
Psychopathology and psychosocial functioning among young people with first-episode psychosis and/or first-presentation borderline personality disorder	11
Access to cognitive remediation in Australia for people with schizophrenia	11
Racial disparities in utilization of first-generation versus second-generation long-acting injectable antipsychotics in Medicaid beneficiaries with schizophrenia	11
Assessment of patient life engagement in schizophrenia using items from the Positive and Negative Syndrome Scale	11
Combining cognitive behavioral therapy and group training for social skills and cognition to improve negative symptoms in patients with psychotic disorders: a randomized controlled pilot trial	11